candoxatril has been researched along with Body Weight in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, H; Kugiyama, K; Matsumura, T; Ohta, Y; Sugiyama, S; Yasue, H | 1 |
| Horimoto, M; Isobe, Y; Ito, R; Sakimura, M; Tachibana, M | 1 |
| Ikuse, T; Kuro, T; Matsumura, Y; Nose, M; Okahara, A | 1 |
| Arnal, JF; Bayard, F; Castano, C; Darblade, B; Gourdy, P; Maupas, E; Michel, JB; Mugniot, A | 1 |
4 other study(ies) available for candoxatril and Body Weight
| Article | Year |
|---|---|
Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11).
Topics: Administration, Oral; Animals; Aorta, Thoracic; Arteriosclerosis; Atrial Natriuretic Factor; Body Weight; Cholesterol, Dietary; Diet, Atherogenic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glycopeptides; Hemodynamics; Hypercholesterolemia; Indans; Lipids; Male; Natriuretic Peptide, C-Type; Neprilysin; Nitroprusside; Organ Culture Techniques; Propionates; Proteins; Rabbits; Substance P; Vasodilation | 1996 |
Reproductive study. II: Prenatal and postnatal development study with candoxatril in Sprague-Dawley rats.
Topics: Animals; Animals, Newborn; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Eating; Embryonic and Fetal Development; Female; Gestational Age; Indans; Male; Memory; Neprilysin; No-Observed-Adverse-Effect Level; Pregnancy; Prodrugs; Propionates; Protease Inhibitors; Rats; Rats, Sprague-Dawley | 1998 |
Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Cardiomegaly; Desoxycorticosterone; Enalapril; Heart; Hypertension; Hypertrophy; Indans; Kidney; Kidney Function Tests; Male; Naphthalenes; Neprilysin; Organ Size; Peptidyl-Dipeptidase A; Propionates; Rats; Rats, Sprague-Dawley; Urea | 2000 |
Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apolipoproteins E; Arteriosclerosis; Atrial Natriuretic Factor; Body Weight; Bradykinin; Cholesterol; Cholesterol, HDL; Drug Evaluation, Preclinical; Indans; Male; Mice; Mice, Knockout; Neprilysin; Propionates; Protease Inhibitors; Pyridines; Substance P; Thiazepines; Triglycerides | 2001 |